CN Patent

CN109939110A — 药根碱在制备抗血栓药物中的应用

Assigned to Hunan University of Chinese Medicine · Expires 2019-06-28 · 7y expired

What this patent protects

本发明涉及医药技术领域，公开了药根碱在制备抗血栓药物中的应用。其作用于内源性凝血途径的接触激活阶段,在发挥抗血栓作用的同时,不延长出血时间,出血副作用轻。本发明还公开了一种以药根碱为活性成分的药物，可制成片剂、胶囊剂或者针剂等多种剂型，可用于防止血栓的形成。

USPTO Abstract

本发明涉及医药技术领域，公开了药根碱在制备抗血栓药物中的应用。其作用于内源性凝血途径的接触激活阶段,在发挥抗血栓作用的同时,不延长出血时间,出血副作用轻。本发明还公开了一种以药根碱为活性成分的药物，可制成片剂、胶囊剂或者针剂等多种剂型，可用于防止血栓的形成。

Drugs covered by this patent

Patent Metadata

Patent number
CN109939110A
Jurisdiction
CN
Classification
—
Expires
2019-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Hunan University of Chinese Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.